Table 2. Clinical-pathological characteristics of the prostate cancer patients.
| Characteristics | CaucasianAmerican | AfricanAmerican |
| Number of patients, n (%) | 15 (37.5) | 25 (62.5) |
| Age at diagnosis | ||
| Mean ± SD (years) | 59.2±5.6 | 59.5±5.7 |
| ≤65, n (%) | 13 (86.6) | 20 (80.0) |
| >65, n (%) | 03 (13.3) | 05 (20.0) |
| Stage, n (%) | ||
| I–II | 12 (80.0) | 21 (84.0) |
| III–IV | 03 (20.0) | 04 (16.0) |
| Primary tumor, n (%) | ||
| pT1–pT2 | 12 (80.0) | 21 (84.0) |
| pT3–pT4 | 03 (20.0) | 04 (16.0) |
| Lymph node metastasis, n (%) | ||
| N0 | 15 (100.0) | 23 (92.0) |
| N1–N4 | 00 (0.0) | 02 (8.0) |
| Gleason sum, n (%) | ||
| ≤6 | 7 (46.0) | 10 (40.0) |
| 7 | 6 (40.0) | 12 (48.0) |
| ≥8 | 2 (13.0) | 03 (12.0) |